TY - JOUR T1 - Remission in Early Rheumatoid Arthritis — A Comparison of New ACR/EULAR Remission Criteria to Established Criteria JF - The Journal of Rheumatology JO - J Rheumatol SP - 1155 LP - 1158 DO - 10.3899/jrheum.111341 VL - 39 IS - 6 AU - BINDEE KURIYA AU - YE SUN AU - GILLES BOIRE AU - BOULOS HARAOUI AU - CAROL HITCHON AU - JANET E. POPE AU - JOHN C. THORNE AU - EDWARD C. KEYSTONE AU - VIVIAN P. BYKERK Y1 - 2012/06/01 UR - http://www.jrheum.org/content/39/6/1155.abstract N2 - Objective. To describe the frequency of remission in an early rheumatoid arthritis (ERA) cohort. Methods. The frequency of remission was evaluated, based on 8 definitions including the Boolean-based American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) criteria. Results. Of 369 patients, remission at 12 months ranged from 18% according to the ACR/EULAR clinical trial criteria to 40% according to the 28-joint Disease Activity Score (DAS28) < 2.6. Higher tender joint count, swollen joint count, and physician global scores were seen for DAS28-based definitions, and patient global assessment (PtGA) scores were almost 5-fold higher for DAS28 remission. Conclusion. Remission is achievable in ERA but its frequency differs according to the remission definition applied. Adoption of the new ACR/EULAR definition will limit the number classified as in remission, especially if the PtGA criteria are rated high for reasons other than inflammatory arthritis. ER -